2 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Recruiting 2 |
Follow Ipx203: new trials by email Literature Review of Ipx203 trials Research Report on Ipx203
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease CREXONT ER - Parkinson Disease | Phase 4 | Recruiting | The Cleveland Clinic | 22 | 2025-07-24 | 2026-10-15 |
| A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease CREXONT ER - Parkinson Disease | Phase 4 | Recruiting | Impax Laboratories, LLC | 220 | 2025-02-12 | 2025-08-24 |
Impax Laboratories, LLC (1) · The Cleveland Clinic (1)
United States (2)
Hester Visser, MD (1) · Hubert Fernandez, MD (1)